| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367826A Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 09/04/2002 | CN1367824A Polypeptides having alkaline alpha-amylase activity and uncleic acids encoding same |
| 09/04/2002 | CN1367790A Moraxella cattarrhalis BASB114 polypeptide antigens and uses thereof |
| 09/04/2002 | CN1367258A Preprartion method of improved hepatoma murine monoclonal antibody |
| 09/04/2002 | CN1367254A Method for producing taxol by means of cell culture |
| 09/04/2002 | CN1367245A Technique for inducing and converting nerve trunk cell into dopaminergic neurons |
| 09/04/2002 | CN1367180A Novel natural antibacterial peptide, its code sequence and application |
| 09/04/2002 | CN1366991A Application of plant extract for preparing medicine to cure bone absorption increment diseases |
| 09/03/2002 | US6444876 Genetic engineering; herbicide, stress resistant plants |
| 09/03/2002 | US6444875 Imidazolinone resistant AHAS mutants |
| 09/03/2002 | US6444871 Expression vector for use in the treatment and prevention of viral diseases |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444802 Human aminopeptidase |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444643 Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity |
| 09/03/2002 | US6444467 Pre-germinating somatic embryos, placing the pre-germinated somatic embryos into a state of physiological dormancy, sowing the pre-germinated physiologically dormant somatic embryos onto or into germination media, and propagating the sown |
| 09/03/2002 | US6444459 Apparatus having pitted or cratered inner surface for culturing biological material and methods thereof |
| 09/03/2002 | US6444454 Method for increasing the gene expression of saccharose synthase |
| 09/03/2002 | US6444446 Calcium binding proteolipid compositions and methods |
| 09/03/2002 | US6444444 Immunogenic composition, comprising at least one nucleic acid fragment as an active component thereof and vector for transformation of a host comprising the nucleic acid fragment |
| 09/03/2002 | US6444441 Production of human mutated proteins in human cells by means of homologous recombination |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | US6444233 Triterpene compositions and methods for use thereof |
| 09/03/2002 | US6444229 Enzymatically digested submucosa of a warm-blooded vertebrate gelled into a shape retaining gel matrix for inducing cell proliferation and growth both in vivo and in vitro; extracellular matrix |
| 09/03/2002 | US6444206 Sepsis therapy; monoclonal antibodies |
| 09/03/2002 | US6444205 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 09/03/2002 | CA2137809C A genetically engineered cell line for detecting infectious herpes simplex virus and method therefor |
| 09/03/2002 | CA2001815C Products and methods for controlling the suppression of the neoplastic phenotype |
| 08/29/2002 | WO2002066989A2 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 08/29/2002 | WO2002066649A2 ANTI-INTERFERON-α ANTIBODIES |
| 08/29/2002 | WO2002066648A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066641A1 Pg-3 and biallelic markers thereof |
| 08/29/2002 | WO2002066636A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | WO2002066631A1 Antibodies recognizing helicobacter pylori and method of detecting helicobacter pylori |
| 08/29/2002 | WO2002066630A1 Methods of modifying eukaryotic cells |
| 08/29/2002 | WO2002066622A2 Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
| 08/29/2002 | WO2002066620A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 08/29/2002 | WO2002066619A1 Methods of treating inflammation, particularly diabetes |
| 08/29/2002 | WO2002066618A1 Rapid production of monoclonal antibodies |
| 08/29/2002 | WO2002066615A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066614A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066613A2 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066612A2 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
| 08/29/2002 | WO2002066603A2 Chemically defined medium for cultured mammalian cells |
| 08/29/2002 | WO2002066599A2 Efficient method for the development of transgenic plants by gene manipulation |
| 08/29/2002 | WO2002066509A2 Treatment involving dkk-1 or antagonists thereof |
| 08/29/2002 | WO2002066507A2 Histidine phosphatase interacting protein of 120 kd |
| 08/29/2002 | WO2002066505A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066053A2 Method of treating or preventing disease characterized by cryptococcus neoformans infection |
| 08/29/2002 | WO2002065992A2 A cell therapy method for the treatment of tumors |
| 08/29/2002 | WO2002065943A2 Ocular tear growth factor-like protein |
| 08/29/2002 | WO2002044338A3 Growth of human dendritic cells for cancer immunotherapy in closed system using microcarrier beads |
| 08/29/2002 | WO2002036787A3 Herbicide-tolerant plants through bypassing metabolic pathway |
| 08/29/2002 | WO2002032480A3 Microstructures for delivering a composition cutaneously to skin |
| 08/29/2002 | WO2002022795A3 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 08/29/2002 | WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002004001A3 A composition for the delivery of live cells and methods of use |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001085952A3 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 08/29/2002 | WO2001085944A3 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 08/29/2002 | WO2001083751A3 Methods for binding an exogenous molecule to cellular chromatin |
| 08/29/2002 | WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001070816A3 Ecdysone receptor-based inducible gene expression system |
| 08/29/2002 | WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | WO2001064903A3 Novel human transferase proteins and polynucleotides encoding the same |
| 08/29/2002 | WO2001007481A9 Antitumor antibodies, proteins, and uses thereof |
| 08/29/2002 | WO2000068382A9 PrP-LIKE GENE |
| 08/29/2002 | WO2000066709A9 Zymogen activation system |
| 08/29/2002 | WO2000061606A9 Novel human voltage-gated potassium channel |
| 08/29/2002 | WO2000059515A9 Immunomodulating polymers |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO2000034447A9 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 08/29/2002 | US20020120959 Genetic sequences encoding substrate-specific dihydroflavonol 4-reductase and uses therefor |
| 08/29/2002 | US20020120954 Genetic sequences encoding substrate-specific dihydroflavonol 4-reductase and uses therefor |
| 08/29/2002 | US20020120950 A homogenous cell mixture spontaneously sorting to form discrete first and second layers, e.g. keratinocytes and fibroblasts, and having a connective tissue component; skin grafts: testing a response to a chemical or a drug |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120947 Protein-protein interactions in neurodegenerative disorders |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020120117 Polynucleotide that exhibits urothelial cell-specific transcriptional response element (TRE) activity; adenoviral vectors which replicate preferentially in urothelial cells; treating bladder cancer for example |
| 08/29/2002 | US20020120114 Pesticidal toxins and genes from bacillus laterosporus strains |
| 08/29/2002 | US20020120103 17 human secreted proteins |
| 08/29/2002 | US20020120098 Enhanced stimulation of erythropoiesis |
| 08/29/2002 | US20020119942 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/29/2002 | US20020119929 Fertility; genetic engineering |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119919 Nucleic acids, proteins, and antibodies |
| 08/29/2002 | US20020119571 Stimulating lymphocytes of graft recipient by cells of graft donor or by cells expressing dominant Major Histocompatability Complex-molecules while transduced with immunmodulatory genes using gene transfer; prevents rejection of allogeneic grafts |
| 08/29/2002 | US20020119568 Providing a population of cells having a target cell surface molecule, a culture vessel and magnets, vessel contains a solid surface having attached thereto a ligand for a target cell surface molecule, applying magnetic field |
| 08/29/2002 | US20020119567 Cost effective media for large scale insect cell culture |